Rheumatology

  • Antibody-mediated autoimmune encephalitis: A practical approach

    Justin R. Abbatemarco, MD, Chen Yan, MD, Amy Kunchok, MBBS and Alexander Rae-Grant, MD, FAAN, FRCPC
    • Cleveland Clinic Journal of Medicine August 2021, 88 (8) 459-471;
    • DOI: https://doi.org/10.3949/ccjm.88a.20122

    • Symptoms may include subacute, progressive neuropsychiatric symptoms with associated cognitive dysfunction, movement disorders, and autoimmune seizures.

  • Shedding light on subungual digital mucous cysts

    Taylor Bullock, BS, Daniel Michalik, MD, Rashmi Unwala, MD and John Anthony, MD
    • Cleveland Clinic Journal of Medicine August 2021, 88 (8) 426-427;
    • DOI: https://doi.org/10.3949/ccjm.88a.20125

    • Transillumination is a quick and easy way to diagnose digital mucous cysts and rule out other subungual masses.

  • Autoimmune brain disease: Think before testing

    Brian F. Mandell, MD, PhD
    • Cleveland Clinic Journal of Medicine August 2021, 88 (8) 420-421;
    • DOI: https://doi.org/10.3949/ccjm.88b.08021

    • Immune serologic tests are not specific for any defined clinical diagnosis and thus should not be used to drive therapeutic decisions.

  • Statin intolerance and new lipid-lowering treatments

    Oltion Mesi, MD, Charlie Lin, MD, Haitham Ahmed, MD, MPH and Leslie S. Cho, MD
    • Cleveland Clinic Journal of Medicine July 2021, 88 (7) 381-387;
    • DOI: https://doi.org/10.3949/ccjm.88a.20165

    • The benefits and safety of statin therapy are clear, but adverse effects continue to pose diagnostic and therapeutic challenges.

  • Promoting physical activity in older women to maximize health

    Augustine Chavez, MD, Robert Scales, PhD and Juliana M. Kling, MD, MPH
    • Cleveland Clinic Journal of Medicine July 2021, 88 (7) 405-415;
    • DOI: https://doi.org/10.3949/ccjm.88a.20170

    • The optimal type, intensity, and level required to achieve specific health outcomes depend on the disease the patient and clinician are trying to prevent or manage.

  • Evolving distal signs

    Zackary D. Goff, MD, Sandra E. Zaeh, MD, MS, Michael K. Poku, MD, John N. Aucott, MD and Allan C. Gelber, MD
    • Cleveland Clinic Journal of Medicine June 2021, 88 (6) 310-312;
    • DOI: https://doi.org/10.3949/ccjm.88a.20126

    • The patient’s evolving signs and symptoms prompted a reconsideration of his diagnosis.

  • Quetiapine for primary insomnia: Consider the risks

    Vania Modesto-Lowe, MD, MPH, Agata K. Harabasz, MD and Sophia A. Walker, MD
    • Cleveland Clinic Journal of Medicine May 2021, 88 (5) 286-294;
    • DOI: https://doi.org/10.3949/ccjm.88a.20031

    • Its cardiometabolic effects and potential for abuse warrant caution in off-label use.

  • Post-acute sequelae of SARS-CoV-2 infection: Caring for the ‘long-haulers’

    Susan Vehar, MD, Marina Boushra, MD, Prince Ntiamoah, MD and Michelle Biehl, MD, MS
    • Cleveland Clinic Journal of Medicine May 2021, 88 (5) 267-272;
    • DOI: https://doi.org/10.3949/ccjm.88a.21010

    • An estimated 10% of COVID-19 survivors continue to experience symptoms weeks to months after symptoms appear.

  • COVID-19: An unwelcome guest that won’t leave

    Brian F. Mandell, MD, PhD
    • Cleveland Clinic Journal of Medicine May 2021, 88 (5) 254-255;
    • DOI: https://doi.org/10.3949/ccjm.88b.05021

    • Long-lasting economic and societal effects, and lingering post-infection symptoms.

  • What is causing the ‘long-hauler’ phenomenon after COVID-19?

    Leonard H. Sigal, MD, FACP, FACR, MACR
    • Cleveland Clinic Journal of Medicine May 2021, 88 (5) 273-278;
    • DOI: https://doi.org/10.3949/ccjm.88a.21009

    • We are still early in our understanding of COVID-19 and its many manifestations.

Previous
Next